The rapper will perform the 2025 Super Bowl Half Time Show on February 9, 2025, and will be cheered on by his high school sweetheart and fiancée Whitney Alford, and their two children ...

Meet Vidhi Shanghvi, daughter of billionaire Dilip Shanghvi, who has a staggering net worth of Rs 2,46,658 Crore. Find out more about the heir to the Rs 4.35 lakh Crore business empire ...

Voters are even wondering about her marital status and whether or not she has any children. In his announcement, Trump called Bondi a “smart and tough” person, whom he’s known for “many ...

Here are all the details about Aalok Shanghvi and Sun Pharma. Shanghvi, son of Sun Pharma MD Dilip Shanghvi, joined Sun Pharma in 2006 and has handled various roles in marketing, R&D, project ...

The child tax credit is a tax break that applies a credit to your income taxes for a qualifying child or children, potentially earning you a refund on your federal tax return. The value of the ...

Pursuant to the Award, NHAI is liable to pay the Dilip Buildcon Limited the said amount forthwith. In the event NHAI fails to pay the said amount an interest at a rate of 2 percent above the SBI base ...

Sun Pharma has announced the Company has designated Aalok Shanghvi - Whole-time Director and Executive Vice-President, Emerging Markets, Global Generic R&D, Global Business Development (Generics), ...

Former LA Times reporter Alan Abrahamson, who covered the Menendez brothers' trials, calls them "stone cold killers," urging focus on facts. Susan Smith, convicted nearly 30 years ago for drowning ...

Shanghvi, who joined the company in 2006, currently designated as Whole-time Director and Executive Vice-President, Emerging Markets, Global Generic R&D, Global Business Development (Generics), ...

Sun Pharma, a leading pharmaceutical company, announced Monday the appointment of Aalok Shanghvi ... Executive Vice-President, Shanghvi brings to his new role extensive experience in various sectors, ...

on Monday said it has elevated Aalok Shanghvi as Chief Operating Officer. He is currently designated as Whole-time Director and Executive Vice-President, Emerging Markets, Global Generic R&D, Global ...